Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium

Andrew J. Portuguese, James A. Davis, Shahzad Raza, Omar Castaneda Puglianini, Ciara Freeman, Melissa Alsina, Corbin Wright, Brandon J. Blue, Rachid C. Baz, Kenneth H. Shain, Utkarsh Goel, Jack Khouri, Faiz Anwer, Hossam M. Ali, Oren Pasvolsky, Mahmoud Gaballa, Krina Patel, Hector Garcia-Pleitez, Damian Mikulski, Lindsay Fogel, Eli Zolotov, Aishwarya Sannareddy, Aimaz Afrough, Larry D. Anderson, Kelley Julian, Danai Dima, Rahul Banerjee, Emily C. Liang, Raffaella Cassano Cassano, Megan M. Herr, Hamza Hassan, Leyla Shune, Jeries Kort, Shonali Midha, Omar Nadeem, Surbhi Sidana, Yi Lin, Frederick L. Locke, Doris K. Hansen, Douglas Sborov, Noa Biran, Ariel Grajales-Cruz

Open source

DOI: 10.1038/s41408-026-01477-z
Published: 2026-03-27
Container: Blood Cancer Journal
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-026-01477-z,
  title = {Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium},
  author = {Andrew J. Portuguese and James A. Davis and Shahzad Raza and Omar Castaneda Puglianini and Ciara Freeman and Melissa Alsina and Corbin Wright and Brandon J. Blue and Rachid C. Baz and Kenneth H. Shain and Utkarsh Goel and Jack Khouri and Faiz Anwer and Hossam M. Ali and Oren Pasvolsky and Mahmoud Gaballa and Krina Patel and Hector Garcia-Pleitez and Damian Mikulski and Lindsay Fogel and Eli Zolotov and Aishwarya Sannareddy and Aimaz Afrough and Larry D. Anderson and Kelley Julian and Danai Dima and Rahul Banerjee and Emily C. Liang and Raffaella Cassano Cassano and Megan M. Herr and Hamza Hassan and Leyla Shune and Jeries Kort and Shonali Midha and Omar Nadeem and Surbhi Sidana and Yi Lin and Frederick L. Locke and Doris K. Hansen and Douglas Sborov and Noa Biran and Ariel Grajales-Cruz},
  year = {2026},
  journal = {Blood Cancer Journal},
  doi = {10.1038/s41408-026-01477-z},
  url = {https://doi.org/10.1038/s41408-026-01477-z}
}

RIS

TY  - JOUR
TI  - Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium
AU  - Andrew J. Portuguese
AU  - James A. Davis
AU  - Shahzad Raza
AU  - Omar Castaneda Puglianini
AU  - Ciara Freeman
AU  - Melissa Alsina
AU  - Corbin Wright
AU  - Brandon J. Blue
AU  - Rachid C. Baz
AU  - Kenneth H. Shain
AU  - Utkarsh Goel
AU  - Jack Khouri
AU  - Faiz Anwer
AU  - Hossam M. Ali
AU  - Oren Pasvolsky
AU  - Mahmoud Gaballa
AU  - Krina Patel
AU  - Hector Garcia-Pleitez
AU  - Damian Mikulski
AU  - Lindsay Fogel
AU  - Eli Zolotov
AU  - Aishwarya Sannareddy
AU  - Aimaz Afrough
AU  - Larry D. Anderson
AU  - Kelley Julian
AU  - Danai Dima
AU  - Rahul Banerjee
AU  - Emily C. Liang
AU  - Raffaella Cassano Cassano
AU  - Megan M. Herr
AU  - Hamza Hassan
AU  - Leyla Shune
AU  - Jeries Kort
AU  - Shonali Midha
AU  - Omar Nadeem
AU  - Surbhi Sidana
AU  - Yi Lin
AU  - Frederick L. Locke
AU  - Doris K. Hansen
AU  - Douglas Sborov
AU  - Noa Biran
AU  - Ariel Grajales-Cruz
PY  - 2026
JO  - Blood Cancer Journal
DO  - 10.1038/s41408-026-01477-z
UR  - https://doi.org/10.1038/s41408-026-01477-z
ER  -

APA

Portuguese, A. J., Davis, J. A., Raza, S., Puglianini, O. C., Freeman, C., Alsina, M., Wright, C., Blue, B. J., Baz, R. C., Shain, K. H., Goel, U., Khouri, J., Anwer, F., Ali, H. M., Pasvolsky, O., Gaballa, M., Patel, K., Garcia-Pleitez, H., Mikulski, D., Fogel, L., Zolotov, E., Sannareddy, A., Afrough, A., Anderson, L. D., Julian, K., Dima, D., Banerjee, R., Liang, E. C., Cassano, R. C., Herr, M. M., Hassan, H., Shune, L., Kort, J., Midha, S., Nadeem, O., Sidana, S., Lin, Y., Locke, F. L., Hansen, D. K., Sborov, D., Biran, N., & Grajales-Cruz, A. (2026). Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01477-z

Source records

crossref · retrieved 2026-09-26T15:20:27.387Z